[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336017-105":59,"doc-detail-336017-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","vacuolar-proton-translocating-atpase-may-take-part-in-the-drug-resistance-phenotype-of-glioma-stem-cells","Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells","","The vacuolar proton-translocating ATPase (V-ATPase) is described as a transmembrane multi-protein complex essential for maintaining normal intracellular pH, while tumor cells exploit it to support metabolism and export chemotherapy agents as a drug resistance strategy. In glioblastoma (GBM), V-ATPase expression is reported to be upregulated and proposed as a therapeutic target. The study evaluates bafilomycin A1-induced V-ATPase inhibition in patient-derived glioma stem cell lines, alone and combined with temozolomide, with results not overcoming standard therapy resistance. Bafilomycin A1 at nanomolar doses blocks autophagy and causes cellular necrosis, limiting usability in more complex models. Increased V-ATPase expression following treatment suggests a critical role in GBM stem components and motivates new approaches to restrict pump activity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/vacuolar-proton-translocating-atpase-may-take-part-in-the-drug-resistance-phenotype-of-glioma-stem-cells/336017/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/vacuolar-proton-translocating-atpase-may-take-part-in-the-drug-resistance-phenotype-of-glioma-stem-cells/336017.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does V-ATPase play in glioblastoma drug resistance?","Question",{"text":112,"@type":113},"V-ATPase helps maintain intracellular pH and supports tumor survival by enabling cells to extrude chemotherapy drugs into the extracellular compartment, contributing to chemoresistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What was the experimental approach using bafilomycin A1?",{"text":117,"@type":113},"The study tested bafilomycin A1-induced inhibition of V-ATPase in patient-derived glioma stem cell lines and compared it with temozolomide, including evaluation of treatment outcomes versus resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"Why did the proposed treatment fail to overcome resistance to standard therapy?",{"text":121,"@type":113},"The results are described as not overcoming resistance to the standard therapy, contrasting with previously published data.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336017,1790190534,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Article  \nVacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells  \nMartina Giambra 1,2,3, Andrea Di Cristofori 1,2,3,4, Francesca Raimondo 2,3, Roberta Rigolio 3, Donatella Conconi 3, Gaia Chiarello 2,5, Silvia Maria Tabano 6,7, Laura Antolini 3, Gabriella Nicolini 2,3, *, Miriam Bua 3,4, Davide Ferlito 3,4, Giorgio Carrabba 2,3,4, Carlo Giorgio Giussani 2,3,4,  \nMarialuisa Lavitrano 2,3 and Angela Bentivegna 2,3, *  \nCitation: Giambra, M.; Di Cristofori, A.; Raimondo, F.; Rigolio, R.; Conconi, D.; Chiarello, G.; Tabano, S.M.;  \nAntolini, L.; Nicolini, G.; Bua, M.; et al. Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells. Int.  \nJ. Mol. Sci. 2024, 25, 2743. [https://](https://)[ ](https://)[doi.org/10.3390/ijms25052743](doi.org/10.3390/ijms25052743)  \nAcademic Editor: Alexander  \nY. Tsygankov  \nReceived: 31 January 2024  \nRevised: 15 February 2024  \nAccepted: 23 February 2024  \nPublished: 27 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 PhD Program in Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy; [m.giambra1@campus.unimib.it](m.giambra1@campus.unimib.it) (M.G.); [a.dicristofori@campus.unimib.it](a.dicristofori@campus.unimib.it) (A.D.C.)  \n2 GBM-BI-TRACE (GlioBlastoMa-BIcocca-TRAnslational-CEnter), University of Milano-Bicocca,  \n20900 Monza, Italy; [francesca.raimondo@unimib.it](francesca.raimondo@unimib.it) (F.R.); [gaia.chiarello@irccs-sangerardo.it](gaia.chiarello@irccs-sangerardo.it) (G.C.); [giorgio.carrabba@unimib.it](giorgio.carrabba@unimib.it) (G.C.); [carlo.giussani@unimib.it](carlo.giussani@unimib.it) (C.G.G.); marialuisa.lavitrano@unimib.it (M.L.)  \n3 School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy;  \n[roberta.rigolio@unimib.it](roberta.rigolio@unimib.it) (R.R.); [donatella.conconi@unimib.it](donatella.conconi@unimib.it) (D.C.); [laura.antolini@unimib.it](laura.antolini@unimib.it) (L.A.);  \n[m.bua@campus.unimib.it](m.bua@campus.unimib.it) (M.B.); d.ferlito1@campus.unimib.it (D.F.)  \n4 Neurosurgery, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy  \n5 Pathology, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy  \n6 Laboratory of Medical Genetics, Ospedale Maggiore Policlinico, IRCCS Ca’ Granda, 20122 Milan, Italy; [silvia.tabano@unimi.it](silvia.tabano@unimi.it)  \n7 Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy  \n* Correspondence: [gabriella.nicolini@unimib.it](gabriella.nicolini@unimib.it) (G.N.); [angela.bentivegna@unimib.it](angela.bentivegna@unimib.it) (A.B.)  \nAbstract: The vacuolar proton-translocating ATPase (V-ATPase) is a transmembrane multi-protein complex fundamental in maintaining a normal intracellular pH. In the tumoral contest, its role is crucial since the metabolism underlying carcinogenesis is mainly based on anaerobic glycolytic reactions. Moreover, neoplastic cells use the V-ATPase to extrude chemotherapy drugs into the extracellular compartment as a drug resistance mechanism. In glioblastoma (GBM), the most malignant and incurable primary brain tumor, the expression of this pump is upregulated, making it a new possible therapeutic target. In this work, the bafilomycin A1-induced inhibition of V-ATPase inpatient-derived glioma stem cell (GSC) lines was evaluated together with temozolomide, the first-line therapy against GBM. In contrast with previous published data, the proposed treatment did not overcome resistance to the standard therapy. In addition, our data showed that nanomolar dosages of bafilomycin A1 led to the blockage of the autophagy proces","cbCaioZeWF9oif0J","https://ap.wps.com/l/cbCaioZeWF9oif0J","pdf",4939616,17,"English","# Introduction\n## Current treatment and chemotherapy rationale","[{\"question\":\"What role does V-ATPase play in glioblastoma drug resistance?\",\"answer\":\"V-ATPase helps maintain intracellular pH and supports tumor survival by enabling cells to extrude chemotherapy drugs into the extracellular compartment, contributing to chemoresistance.\"},{\"question\":\"What was the experimental approach using bafilomycin A1?\",\"answer\":\"The study tested bafilomycin A1-induced inhibition of V-ATPase in patient-derived glioma stem cell lines and compared it with temozolomide, including evaluation of treatment outcomes versus resistance.\"},{\"question\":\"Why did the proposed treatment fail to overcome resistance to standard therapy?\",\"answer\":\"The results are described as not overcoming resistance to the standard therapy, contrasting with previously published data.\"}]","Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells | PDF",1790013200,43]